Shares of Vertex Pharmaceuticals Inc. VRTX slipped 2.92% to $485.89 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to ...

As the U.S. stock market navigates a period of heightened volatility, with major indexes experiencing significant fluctuations amid tariff discussions and economic uncertainties, investors are keenly ...

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ ... and lead a panel discussion at the World Vaccine Congress Washington 2025, taking place April 22–24 in Washington, D.C ...

WASHINGTON, April 16 (Reuters) - The administration of U.S. President Donald Trump is looking to cut some $40 billion in funding from its Department of Health and Human Services, the Washington ...

The fallout continues following Jeffrey Goldberg’s report that top members of President Trump’s national security team discussed military attack plans in a Signal group chat that inadvertently ...

ARLINGTON, Va. – The Washington Capitals announced today ALL CAPS 2025 Playoffs initiatives presented by Vanda Pharmaceuticals Inc. surrounding the Eastern Conference First Round of the Stanley ...